Purpose
to restart and sustain WHO-prequalified yellow fever vaccine production in Africa, ensuring reliable and affordable supply for populations most at risk.
Grantee
Division
Global Health
Date
NOVEMBER 2025
Region served
AFRICA
Committed amount
$3,744,330
Grant topic
Vaccine Development
Duration (months)
14
Grantee location
Dakar, Senegal
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.